COMMUNIQUÉS West-GlobeNewswire

Agritek Holdings, Inc. Announces Resignation of CEO, Names New Interim CEO, With Company To Bring On New Advisory Board And Management Consultants Specializing In Cannabis Sector
10/12/2018
LOS ANGELES, CA, Dec. 10, 2018 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE – Agritek Holdings, Inc. (OTC PINK: AGTK) www.AgritekHoldings.com , a fully integrated, active real estate investor for the cannabis sector in the [...]
Eve & Co Receives Expanded Health Canada Licences
10/12/2018
TORONTO, Dec. 10, 2018 (GLOBE NEWSWIRE) -- Eve & Co Incorporated (TSX-V: EVE; OTCQB: EEVVF) (“Eve & Co” or the “Company”) is pleased to announce that as of December 7, 2018, Health Canada authorized Natural [...]
Abattis to Display Products and Services at O’Cannabiz Conference on December 10-11th, 2018
10/12/2018
VANCOUVER, British Columbia, Dec. 10, 2018 (GLOBE NEWSWIRE) -- Abattis Bioceuticals Corp (the “ Company ” or “ Abattis ”) (CSE:ATT) (OTC:ATTBF) is pleased to announce that the Company will be displaying a booth at the O [...]
Achaogen Announces FDA Clearance and Launch of the Thermo Scientific QMS Plazomicin Immunoassay
10/12/2018
Thermo Fisher Scientific and Achaogen jointly develop new assay to enable Therapeutic Drug Management SOUTH SAN FRANCISCO, Calif., Dec. 10, 2018 (GLOBE NEWSWIRE) -- Achaogen, Inc. (NASDAQ: AKAO), a biopharmaceutical [...]
Allscripts to sell its interests in Netsmart
10/12/2018
CHICAGO, Dec. 10, 2018 (GLOBE NEWSWIRE) -- Allscripts (NASDAQ: MDRX), a global leader in healthcare information technology, today announced that it has signed a definitive agreement to sell its interests in Netsmart [...]
Sientra Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
10/12/2018
SANTA BARBARA, Calif., Dec. 10, 2018 (GLOBE NEWSWIRE) -- Sientra, Inc. (NASDAQ:SIEN) (“Sientra” or the “Company”), a medical aesthetics company, today announced that on December 5, 2018, the Compensation Committee of [...]
Introducing The Diamond CBD Referral Program Give $25 and Receive $25 by Referring a Friend
10/12/2018
FT LAUDERDALE, Fla., Dec. 10, 2018 (GLOBE NEWSWIRE) -- via OTC PR WIRE-- Diamond CBD, Inc., wholly owned subsidiary of PotNetwork Holdings, Inc. (OTC Pink: POTN ) is pleased to announce the successful introduction to [...]
Nkarta Therapeutics Announces Appointment of Matthew Plunkett, Ph.D., as Chief Financial Officer
10/12/2018
SOUTH SAN FRANCISCO, Calif., Dec. 10, 2018 (GLOBE NEWSWIRE) -- Nkarta Therapeutics, a privately-held cell therapy company developing engineered Natural Killer (NK) immune cells to fight cancer, today announced that [...]
Genocea Appoints Girish Aakalu, Ph.D., Chief Business Officer
10/12/2018
Role to focus on business development as Genocea expands its immunotherapy pipeline and explores additional applications of its ATLAS™ neoantigen identification platform CAMBRIDGE, Mass., Dec. 10, 2018 (GLOBE NEWSWIRE [...]
Catalyst Biosciences to Host a Research & Development Day Focused on Factor VIIa and Factor IX Hemophilia Programs
10/12/2018
SOUTH SAN FRANCISCO, Calif., Dec. 10, 2018 (GLOBE NEWSWIRE) -- Catalyst Biosciences, Inc. (NASDAQ: CBIO), a clinical-stage biopharmaceutical company focused on developing novel medicines to address hematology [...]
Molina Healthcare Selects Inovalon to Provide Data-Driven Insights to Improve Member Care
10/12/2018
Leading Health Plan Applies Inovalon ONE® Platform Capabilities Across All Product Lines BOWIE, Md., Dec. 10, 2018 (GLOBE NEWSWIRE) -- Inovalon (Nasdaq: INOV), a leading technology company providing advanced, cloud- [...]
CBT Pharmaceuticals and Strata Oncology Announce Collaboration to Accelerate Development of CBT-101, a c-Met inhibitor, for Patients with Non-Small Cell Lung Cancer and other Solid Tumors
10/12/2018
PLEASANTON, Calif., HANGZHOU, China and ANN ARBOR, Mich., Dec. 10, 2018 (GLOBE NEWSWIRE) -- CBT Pharmaceuticals (CBT), Inc., a U.S. and China-based innovative pharmaceutical company, and Strata Oncology, Inc., a [...]
Elite Pharmaceuticals and SunGen Pharma Receive FDA Approval for Generic Adderall®
10/12/2018
NORTHVALE, N.J., Dec. 10, 2018 (GLOBE NEWSWIRE) -- Elite Pharmaceuticals, Inc. ("Elite" or the “Company") (OTCBB: ELTP) a specialty pharmaceutical company developing abuse-deterrent opioids and niche generic products, [...]
Onconova Welcomes Avi Oler, JD, MBA, as Vice President, Corporate Development and General Counsel
10/12/2018
Mr. Oler joins Onconova’s management team as Vice President, Corporate Development and General Counsel, after an impactful tenure at Spectrum Pharmaceuticals Hiring reflects Onconova’s commitment to execute business [...]
Novan Announces Full Top Line Results from Phase 2 Molluscum Contagiosum Clinical Trial and Decision to Move Forward with SB206 12% Once-Daily
10/12/2018
SB206 12% once-daily achieved the highest rate of complete clearance out of all active treatment groups at Week 12 (p<0.05) Statistically significant reductions in molluscum lesions as early as Week 2 with 12% once- [...]
Marinus Pharmaceuticals Announces Positive Ganaxolone Data in Women With Postpartum Depression
10/12/2018
Ganaxolone was safe and well-tolerated Ganaxolone IV demonstrated fast-acting, robust and durable efficacy Interim data with ganaxolone oral supports IV to oral administration Conference call to be held today at 8:30 AM [...]
Cytokinetics Announces New Data Presented at the International Symposium on ALS/MND
10/12/2018
Baseline Characteristics and Demographics from FORTITUDE-ALS Similar to Other Recent Large Trials in ALS SOUTH SAN FRANCISCO, Calif., Dec. 10, 2018 (GLOBE NEWSWIRE) -- Cytokinetics, Incorporated (Nasdaq: CYTK) today [...]
Apotheca Biosciences (PCFP) Announces the Roll Out of Apotheca Earth, Direct to Business & Consumer Medical Grade CBD Products - Apotheca Earth to Begin National Sales & Marketing Campaign
10/12/2018
SAINT PETERSBURG, FL, Dec. 10, 2018 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE – Apotheca Biosciences (OTC PINK: PCFP), a developer of cutting-edge medical products, nutraceuticals, drug formulations, and cannabis delivery [...]
Voyager Therapeutics Announces First Patient Dosed in RESTORE-1, a Phase 2 Trial of VY-AADC Gene Therapy for the Treatment of Parkinson’s Disease
10/12/2018
CAMBRIDGE, Mass., Dec. 10, 2018 (GLOBE NEWSWIRE) -- Voyager Therapeutics, Inc. (NASDAQ: VYGR), a clinical-stage gene therapy company focused on developing life-changing treatments for severe neurological diseases, today [...]

Pages